In a sudden reversal, the U.S. Food and Drug Administration (FDA) has agreed to review Moderna’s experimental mRNA influenza vaccine.

As the U.S. backpedals on its mRNA investment, Mexico is embracing the technology through a new manufacturing pact with Moderna to produce vaccines domestically.  | The agreement includes mRNA vaccine ...

In a sudden reversal, the US Food and Drug Administration has agreed to review Moderna’s experimental mRNA influenza vaccine.

Union Health Minister JP Nadda on Saturday launched the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine ...

Viral mimic systems and other tech platforms could enable local testing of vaccine candidates and antiviral therapies. This ...

Union Health Minister J P Nadda launched the indigenously manufactured tetanus and adult diphtheria vaccine in Kasauli. The ...

The programme was established in direct response to the Covid-19 pandemic, during which lower-income countries were consistently last to receive vaccines, with some waiting years while ...

Despite the worldwide effort to develop safe and effective vaccines against COVID-19 and ramp up production capacity, it is inevitable that initial vaccine supply will be limited. Therefore, ...

The global vaccine Contract Development and Manufacturing Organization (CDMO) market is projected to expand at a compound ...

Moderna Inc. MRNA on Tuesday signed a long-term strategic agreement with the Mexican government to enhance local mRNA manufacturing capabilities. Moderna’s Strategic Agreement Boosts Mexico’s mRNA ...

Union Health Minister J.P. Nadda launched India's indigenous Td vaccine, enhancing public health through the Universal ...